Endocan

2

Review clinical trials related to Endocan. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome

This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.

Participants needed: 40
Trial details
Age: 28-36Biological sex: AllType: ObservationalSponsor: Tanta UniversityUpdated: Sep 4, 2025Locations: 1
Eligibility criteria

Prematurity. [+2]

Intrauterine growth restriction (IUGR). [+7]

Status: Not yet recruiting

Effect of Non-surgical Periodontal Therapy in Hypertensive Patients With Assessment of Endocan and TNF-α Levels in GCF

There is a strong crossway relationship between periodontitis and hypertension. Hypertension is the most prevalent of cardiovascular diseases and its prevalence is increased by the presence of periodontitis. Periodontal attachment loss is higher in hypertension patients when compared to healthy subjects. Both are examples of non-communicable diseases (NCDs), also known as chronic inflammatory diseases, they tend to be of long duration and are the result of a combination of genetic, physiological and environmental factors. The lack of an appropriate balance between these factors results in cellular changes as well as the levels of cytokines with subsequent changes in clinical manifestations of periodontal diseases. Both periodontitis and hypertension are associated with inflammation and an increase in specific proinflammatory cytokines. Aim of the study: To investigate the correlation between the clinical parameters and the levels of Endocan and TNF-α in gingival crevicular fluid (GCF) before and after non-surgical periodontal therapy (NSPT) in stage II periodontitis patients with hypertension in comparison to non-hypertensive patients.

Participants needed: 40
Trial details
Age: 30-70Biological sex: AllType: ObservationalSponsor: Ain Shams UniversityUpdated: Jan 30, 2025Duration: 3 Months
Eligibility criteria

Patients with stage II periodontitis and controlled hypertension (self-reported... [+4]

Smokers. [+4]